Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
Comparison Results
Keymed Biosciences, Inc.
HK$71.25
HK$20.87B
―
70.25%
1 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$10.50
HK$10.87B
―
677.78%
1 Buy
1 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$12.62
HK$33.74B
33.68
94.45%
1 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$7.23
HK$14.44B
―
112.65%
0 Buy
0 Hold
0 Sell
Hold
CARsgen Therapeutics Holdings Ltd.
HK$19.30
HK$12.53B
―
306.32%
0 Buy
0 Hold
0 Sell
Moderate Sell
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$25.56
HK$10.92B
74.60
233.68%
0 Buy
0 Hold
0 Sell
Hold
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
71.25
30.25
73.78%
HK:1672
Ascletis Pharma, Inc.
10.50
9.20
707.69%
HK:2096
Simcere Pharmaceutical Group Limited
12.62
6.45
104.54%
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.23
4.15
134.74%
HK:2171
CARsgen Therapeutics Holdings Ltd.
19.30
15.06
355.19%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
25.56
18.40
256.98%